Suchergebnisse - "Stagno, Fabio"

PubPharm (23)

1

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia : A study from the Registro Italiano LMC and Campus CML

enthalten in: Cancer | 2023

von Tiribelli, M. | Latagliata, R. | Breccia, M. | +38

2

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

3

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

4

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs : First interim analysis of OPTkIMA study

enthalten in: Cancer medicine | 2021

von Malagola, M. | Iurlo, A. | Abruzzese, E. | +29

ErratumIn: Cancer Med. 2021 May 2;:. - PMID 33934555

5

Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia Patients

enthalten in: Anticancer research | 2020

von Markovic, U. | Bulla, A. | Leotta, S. | +6

6

Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors

enthalten in: International journal of cardiology | 2020

von Caocci, G. | Mulas, O. | Annunziata, M. | +31

7

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

enthalten in: Leukemia | 2020

von Efficace, F. | Stagno, F. | Iurlo, A. | +20

8

Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript : A Case Report

enthalten in: Anticancer research | 2019

von Massimino, M. | Stella, S. | Tirrò, E. | +9

9

Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

enthalten in: Journal of cellular and molecular medicine | 2018

von Giallongo, C. | Parrinello, N. | La Cava, P. | +9

10

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series

enthalten in: Annals of hematology | 2018

von Iurlo, A. | Galimberti, S. | Abruzzese, E. | +29